April
Tyler Beveridge, MSc'14, PhD'18, is a recipient of The Marilyn Robinson Award for Excellence in Teaching for 2023-24.
Dr. Teresa Chan, MD'08, will be the Founding Dean and Inaugural VP of Medical Affairs at TMU's new medical school. The school is expected to welcome their first cohort in September 2025.
Dr. Chan is also #9 on Maclean's 2024 Power List - Healthcare.
Mitchell Mumby, a PhD candidate supervised by Jimmy Dikeakos, a professor in the department of microbiology and immunology at Schulich School of Medicine & Dentistry, will present his work in isolating various Nef sequences at the Canadian Conference on HIV/AIDS Research (CAHR Conference). The student researcher will also be named as an Academic Scholarship Winner – Basic for the top-ranked abstract by a student.
Mumby’s work involved isolating various sequences of the potent viral HIV-1 accessory protein from a cohort of people with HIV from the Rakai Health Sciences Program, located in the Rakai region of Uganda. His studies showed that Nef works by removing a critical protein called major histocompatibility class I (MHC-I) from cells infected by HIV-1 and fooling the immune system into thinking the virus is gone.
Dr. Kristin Clemens, MD'08, MSc'15, has been appointed as the Diabetes Canada Chair in Diabetes Management at the Schulich School of Medicine & Dentistry, Western University, effective March 1, 2024, to February 28, 2029.
Dr. Clemens is currently an Associate Professor in the Departments of Medicine, Endocrinology and Metabolism, and Epidemiology and Biostatistics at the Schulich School of Medicine & Dentistry. In addition to her faculty appointments, Dr. Clemens is also the current Site Director for ICES Western, Associate Scientist at Lawson Health Research Institute, and Medical Director of the Osteoporosis and Bone Disease Program at St. Joseph’s Health Care London.
Dr. Zain Kassam, MD'08, was appointed as Chief Medical Officer at Seed Health, a microbiome science company. An award-winning physician-scientist, Dr. Kassam has played a pivotal role in the advancement of microbiome science for over a decade. His extensive body of work includes over 200 peer-reviewed publications and abstracts, including in The New England Journal of Medicine, Nature Biotechnology, and Gastroenterology, and co-authoring international clinical practice guidelines. He has championed more than 30 Phase I-III clinical trials with top-tier academic institutions across multiple therapeutic areas. Dr. Kassam has received numerous awards, including the 2020 Public Health Innovator Award from Harvard T.H. Chan School of Public Health, among the most prestigious awards for Alumni.
